Hypromellose in Modern Pharmaceutics: From Advanced Drug Delivery to Process Optimization and Quality Control
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 20 May 2026 | Viewed by 996
Special Issue Editor
Interests: preformulation; polymorphism; PAT; controlled drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Hypromellose (HPMC) is a versatile hydrophilic polymer widely utilized in the pharmaceutical industry for its unique properties that enhance the performance of various drug delivery systems, including as a film-forming agent, tablet binder, and controlled release matrix. It plays a pivotal role in the development of advanced drug delivery systems, process optimization, and quality control, ensuring the efficacy and safety of pharmaceutical products. This Special Issue is dedicated to exploring the multifaceted applications of Hypromellose in modern pharmaceuticals, encompassing innovative formulations, manufacturing processes, and analytical techniques.
The scope of this Special Issue includes, but is not limited to, the following:
- Advanced drug delivery systems utilizing Hypromellose for targeted and controlled release;
- Novel formulations and applications of Hypromellose in oral, transdermal, and other drug delivery routes;
- Process optimization strategies for Hypromellose-based pharmaceutical products;
- Quality control and analytical methods for ensuring the consistency and stability of Hypromellose formulations;
- Case studies and real-world applications of Hypromellose in pharmaceutical manufacturing.
Prof. Dr. Franc Vrečer
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hypromellose excipient formulations
- manufacturing processes
- quality by design
- drug delivery systems
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
